Asciolla J, Wu X, Adamopoulos C, Gavathiotis E, Poulikakos P
Nat Cancer. 2025; 6(1):24-40.
PMID: 39885369
DOI: 10.1038/s43018-024-00893-z.
Horvath R, Brumme Z, Sadowski I
Antimicrob Agents Chemother. 2024; 68(3):e0107223.
PMID: 38319085
PMC: 10923280.
DOI: 10.1128/aac.01072-23.
Pluta A, Studniarek C, Murphy S, Norbury C
Wiley Interdiscip Rev RNA. 2023; :e1816.
PMID: 37718413
PMC: 10909489.
DOI: 10.1002/wrna.1816.
Erzurumlu Y, Doganlar Y, Kubra Dogan H, Catakli D
Turk J Pharm Sci. 2023; 20(3):157-164.
PMID: 37417198
PMC: 10337018.
DOI: 10.4274/tjps.galenos.2022.71643.
Cui G, Zhou J, Ge X, Sun B, Song G, Wang X
Cell Prolif. 2023; 56(5):e13481.
PMID: 37084418
PMC: 10212710.
DOI: 10.1111/cpr.13481.
A ROS-dependent mechanism promotes CDK2 phosphorylation to drive progression through S phase.
Kirova D, Judasova K, Vorhauser J, Zerjatke T, Leung J, Glauche I
Dev Cell. 2022; 57(14):1712-1727.e9.
PMID: 35809563
PMC: 9616724.
DOI: 10.1016/j.devcel.2022.06.008.
Cyclin-dependent kinase inhibitors in brain cancer: current state and future directions.
Juric V, Murphy B
Cancer Drug Resist. 2022; 3(1):48-62.
PMID: 35582046
PMC: 9094053.
DOI: 10.20517/cdr.2019.105.
mTOR Regulation of AGC Kinases: New Twist to an Old Tail.
Baffi T, Newton A
Mol Pharmacol. 2021; 101(4):213-218.
PMID: 34155089
PMC: 9092464.
DOI: 10.1124/molpharm.121.000310.
Cyclin-Dependent Kinases (CDK) and Their Role in Diseases Development-Review.
Lukasik P, Zaluski M, Gutowska I
Int J Mol Sci. 2021; 22(6).
PMID: 33805800
PMC: 7998717.
DOI: 10.3390/ijms22062935.
CDK7 Inhibition Potentiates Genome Instability Triggering Anti-tumor Immunity in Small Cell Lung Cancer.
Zhang H, Christensen C, Dries R, Oser M, Deng J, Diskin B
Cancer Cell. 2019; 37(1):37-54.e9.
PMID: 31883968
PMC: 7277075.
DOI: 10.1016/j.ccell.2019.11.003.
Regulation of Cell Cycle Entry and Exit: A Single Cell Perspective.
Coller H
Compr Physiol. 2019; 10(1):317-344.
PMID: 31853969
PMC: 8208229.
DOI: 10.1002/cphy.c190014.
The CDK7 inhibitor THZ1 alters RNA polymerase dynamics at the 5' and 3' ends of genes.
Sampathi S, Acharya P, Zhao Y, Wang J, Stengel K, Liu Q
Nucleic Acids Res. 2019; 47(8):3921-3936.
PMID: 30805632
PMC: 6486546.
DOI: 10.1093/nar/gkz127.
Cdk7 mediates RPB1-driven mRNA synthesis in Toxoplasma gondii.
Deshmukh A, Mitra P, Maruthi M
Sci Rep. 2016; 6:35288.
PMID: 27759017
PMC: 5069487.
DOI: 10.1038/srep35288.
Selective CDK7 inhibition with BS-181 suppresses cell proliferation and induces cell cycle arrest and apoptosis in gastric cancer.
Wang B, Liu Q, Cao J, Chen J, Liu Z
Drug Des Devel Ther. 2016; 10:1181-9.
PMID: 27042010
PMC: 4801149.
DOI: 10.2147/DDDT.S86317.
Measuring time during early embryonic development.
Ferree P, Deneke V, Di Talia S
Semin Cell Dev Biol. 2016; 55:80-8.
PMID: 26994526
PMC: 4903905.
DOI: 10.1016/j.semcdb.2016.03.013.
Improving the Understanding of Pathogenesis of Human Papillomavirus 16 via Mapping Protein-Protein Interaction Network.
Dong Y, Kuang Q, Dai X, Li R, Wu Y, Leng W
Biomed Res Int. 2015; 2015:890381.
PMID: 25961044
PMC: 4414230.
DOI: 10.1155/2015/890381.
Genome-wide identification and comprehensive analyses of the kinomes in four pathogenic microsporidia species.
Li Z, Hao Y, Wang L, Xiang H, Zhou Z
PLoS One. 2014; 9(12):e115890.
PMID: 25549259
PMC: 4280135.
DOI: 10.1371/journal.pone.0115890.
Androgen receptor phosphorylation: biological context and functional consequences.
Koryakina Y, Ta H, Gioeli D
Endocr Relat Cancer. 2014; 21(4):T131-45.
PMID: 24424504
PMC: 4437516.
DOI: 10.1530/ERC-13-0472.
Development of a cyclin-dependent kinase inhibitor devoid of ABC transporter-dependent drug resistance.
Kaliszczak M, Patel H, Kroll S, Carroll L, Smith G, Delaney S
Br J Cancer. 2013; 109(9):2356-67.
PMID: 24071597
PMC: 3817326.
DOI: 10.1038/bjc.2013.584.
Coordinating cell polarity and cell cycle progression: what can we learn from flies and worms?.
Noatynska A, Tavernier N, Gotta M, Pintard L
Open Biol. 2013; 3(8):130083.
PMID: 23926048
PMC: 3758543.
DOI: 10.1098/rsob.130083.
